Gabriella Abruzzo
Climate Projects Officer, Health Care Without Harm Europe (HCWH)
Jo Taylor is Vice President of Corporate Affairs at Shionogi Europe, where she has worked for the last three years, having set up the function when she joined the company. She is responsible for infectious disease policy – antimicrobial resistance and health security in addition to corporate and brand communications, patient advocacy, internal communications and sustainability in Region Europe and nationally in the affiliate countries.
Jo is a highly accomplished Corporate Affairs professional having worked for GSK, Lilly, Novartis, Daiichi-Sankyo, Astellas, CSL Seqirus and Shionogi in her 33-year career.
Jo also spent a short time leading Public Affairs at the communications agency Cello as well as working on secondment for HMG Business, Energy and Industrial Strategy Department as part of the Vaccines Taskforce during the Covid Pandemic in 2020.
She has been an active member of the HCA throughout her career and led the Foresight Committee for two years.
Climate Projects Officer, Health Care Without Harm Europe (HCWH)
Capacity Building Officer & Patient Advocate, European Patients' Forum (EPF)
President, European Federation of Neurological Associations (EFNA)
President, Standing Committee of European Doctors (CPME)
Secretary General, European Alcohol Policy Alliance
President & CEO, The Ehlers-Danlos Society
Director of Preference Research and Global Lead of the Patient-Centered Outcomes, OPEN Health
MD, Board Member, European Patients' Forum (EPF)
Senior Manager IVD, MedTech Europe
Executive Director, European Regional and Local Health Authorities (EUREGHA)
Director of Operations, Cyprus Federation of Patients’ Associations (CyFPA) and Board Treasurer, European Patients' Forum (EPF)
Researcher & Populariser, Vaccination et Lien Social (VLS)
Senior Research Officer, Swedish Research Council
Chair, Council of Europe Steering Committee for Human Rights in the fields of Biomedicine and Health (CDBIO)
WHO Representative to the EU
Executive Director, EUPATI
Deputy Director-General, Austrian Ministry of Health
Movement Health, Executive Director
Deputy Administrator General, National Institute for Health and Disability Insurance (NIHDI)
President, European Patients' Forum (EPF)
Board Chair, Czech National Association of Patient Organizations (NAPO) & Board Member, European Patients' Forum (EPF)
Director for Executive Education in Government, Health and Non Profit Division, SDA Bocconi
Implementation Scientist & Qualitative Researcher, University of Antwerp
Policy Officer, DG SANTE, European Commission
Youth Group Member, European Patients' Forum (EPF)
President, European Liver Patient Association (ELPA)
Head of Government Affairs, EMEA MedTech, Johnson & Johnson
Professor, Sorbonne Université
Regional Director, WHO/Europe
Youth Group Member, European Patients' Forum (EPF)
Director for Digital, EU4Health and Health systems modernisation, DG SANTE, European Commission
Director General, EFPIA
IMMUcan scientific lead
Director, European Federation of Allergy and Airways Diseases Patients' Associations (EFA)
Senior Economist, Organisation for Economic Co-operation and Development (OECD)
Executive Director, Biomed Alliance
SVP International, Butterfly Network Inc
Director General, AESGP
Vice President Corporate Affairs, Shionogi Europe
Public Affairs Director, OM Pharma
Chief Medical Officer, European Medicines Agency
Prof Dr, Erasmus University Rotterdam
Head of Unit, Policy and Coordination, HERA, European Commission
More speakers Announced soon
Stay Tuned!
CEO, Millwater Partners
Chief Partnership Officer, The Synergist
Regional Innovation Lead, NHS Greater Glasgow and Clyde Board (NHSGGC)
Policy Officer, European Patients' Forum (EPF)
PhD, MBA. Secretary of the Board, HTAi
Policy Officer, European Patients' Forum (EPF)
Head of Policy, European Patients' Forum (EPF)
Interim Executive Director, European Patients' Forum (EPF)
More moderators Announced soon
Stay Tuned!